All Type of News
Finally, Gardasil and Cervarix join in NIP with different prices
On the 12th, the Korea Centers for Disease Control and Prevention(KCDC) announced to make separated agreements on each cervical cancer vaccine which will be vaccinated for children for the age 12 from this June. Like ...
Daewoong-AZ Korea start to jointly sell hyperlipidemia treatment ‘Crestor’
On the 11th, Daewoong Pharmaceutical(CEO Jong-ok Lee) announced it made a strategic joint sales agreement of ‘Crestor(generic name: rosuvastatin),’ a hyperlipidemia treatment, with AstraZeneca(CEO Liz Chatwin), and st...
Multinational pharmaceuticals spent KRW 68 billion last year for early retirements
It was observed multinational pharmaceutical companies branched in the Korean market paid KRW 68 billion as retirement packages for employees last year.
According to the observation data about 26 multinational pharma...
MSD applies for injunction against companies infringing ezetimibe patent
MSD applied for an injunction of sales prohibition against 3 companies, such as Daewoong Pharmaceutical, Handok and Alvogen Korea for infringement of the ezetimibe patent.
The 3 companies including Daewoong Pharmaceu...
GSK and Bayer pushed out from ranking competition, recording low performances
In Korea, sales of GSK(GlaxoSmithKline) and Bayer have continuously decreased.
According to 2015 audit reports turned in to the Financial Supervisory Service, GSK and Bayer Korea were reduced in sales last year compa...
Hypertension drug containing ‘olmesartan’ was taken safety actions(?)
The Ministry of Food and Drug Safety(hereinafter referring to MFDS) has begun to distribute safety letters to domestic medical and consumer associations about ‘olmesartan,’ a substance used for hypertension.
As the ...
“About 10 rebates types will be opened, and pharmaceutical companies tent to indicate a single company”
“Their names and clients(medical institutes) will be removed, but 10 of their rebate types will be unveiled.”
The Korea Pharmaceutical Manufacturers Association attracted interests as shockingly deciding to open type...
Zuellig’s supplies with super-low price, complained by distribution industry“Zuellig Pharma Korea supplies its own multinational products with excessively low prices,” the distribution industry complained.
According to the distribution industry on the...
|
7 of 10 people in Korea acquire inaccurate cancer information via Internet
It was observed 7 of 10 ordinary people in Korea acquire cancer-related information not via doctors or public institutes, but the Internet with overflown inaccurate information. This also occurred even for families of...
Daebong LS records highest R&D personnel ratio, 31%
It was known 1.3 of 10 employees working for a pharmaceutical company are engaged in the R&D field.
According to the collection result of the number of R&D personnel from 25 listed pharmaceutical companies which open...
